Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Dexrazoxane × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 3 Myelodysplastic Syndromes 2 Leukemia, Biphenotypic, Acute 2 Ganglioneuroblastoma 2 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Lymphoma, Large B-Cell, Diffuse 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia 1 Heart Failure 1 Drug-Related Side Effects and Adverse Reactions 1 Dendritic Cell Sarcoma, Interdigitating 1 Degradation of Top2b and Top2a in Human by Dexrazoxane 1 Cardiotoxicity 1 Burkitt Lymphoma 1 Blast Crisis 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Brentuximab Vedotin 5 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 romidepsin 3 pembrolizumab 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡